Advancements in genomic research, such as genome-wide association studies (GWAS), have provided insights into the genetic basis of toxicity. These studies help identify genetic variants associated with adverse responses to chemicals, facilitating the development of biomarkers for susceptibility and providing data for refining risk assessments.
